Johnson & Johnson reported $8.22B in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US $ 2973M 926M
Abiomed ABMD:US $ 69.82M 4.94M
Biogen BIIB:US $ 874.8M 28.6M
Cardiovascular Systems CSII:US $ -9.64M 0.05M
Cooper Companies COO:US $ 186.7M 0.5M
Edwards Lifesciences EW:US $ 451.1M 10.3M
Insulet PODD:US $ -36.1M 65.4M
Medtronic MDT:US $ 2345M 233M
Novartis NOVN:VX SF 4129M 217M
Sanofi SAN:FP € 2660M 305M
Teva Pharmaceutical TEVA:IT -1160000000 189M